Sentence examples for test of recurrence from inspiring English sources

This makes it difficult to determine which gene or genomic locus (if any) is the target of the aberration, a necessary prerequisite for any statistical test of recurrence.

We prove a bound on the number of patients required to detect all driver genes with high probability using a single gene test of recurrence.

In the validation data set from Barrier et al (2006), SOX4 expression in the upper tertile was also associated with a significantly higher incidence (P=0.005, Fisher's exact test) of recurrence and a shorter recurrence-free survival (log-rank test P=0.0092 and univariate cox regression analysis P=0.01; hazard ratio 2.7; 95% CI, 1.2 6.0).

For several reasons 315 samples were duplicates, including dual registration for different local hospitals in the SEWCN, testing of different tumours from the same patient, or testing of recurrences from the same patient, which occurred during follow-up after adjuvant treatment.

Patients with test results suggestive of recurrence or metastasis received additional computed tomography and/or magnetic resonance imaging.

We review the literature on (i) the specificity and heterogeneity of ILC biology as documented by various analytical techniques, including the results of molecular testing for risk of recurrence; (ii) the impact of lobular histology on prediction of prognosis and effect of systemic therapies in patients.

Studies were included if the subluxation or dislocation was confirmed by either radiological evidence or clinical testing and rate of recurrence was documented as an outcome measure.

Several emerging molecular diagnostic assays including the EndoPredict test, the PAM50 risk of recurrence (ROR) score, and the Breast Cancer Index (BCI) tests have demonstrated the ability to specifically assess risk of late recurrence in ER-positive cancers [ 14, 19– 22].

This paper reports the findings of the M.R.C., study into the use of the plasma CEA test for early detection of recurrence following "successful" surgery for colorectal carcinoma.

The test outputs a risk of recurrence (ROR) score, risk category, and intrinsic subtype (Luminal A/B, HER2-enriched, Basal-like).

A commercially available test exists for prediction of recurrence and benefit for 5-fluorouracil chemotherapy (Oncotype DX®; Genomic Health, Redwood City, California, USA), based on a multigene panel of RNA expression from formalin-fixed paraffin-embedded tissues 28.